首页> 美国卫生研究院文献>Neuro-Oncology >THER-04. OLFACTORY ENSHEATHING CELLS TRAVEL THEIR NATURE ROUTE FROM NASAL CAVITY TO CNS AND DELIVER THERAPEUTIC TRANSGENES TO HIGH-GRADE PEDIATRIC GLIOMAS
【2h】

THER-04. OLFACTORY ENSHEATHING CELLS TRAVEL THEIR NATURE ROUTE FROM NASAL CAVITY TO CNS AND DELIVER THERAPEUTIC TRANSGENES TO HIGH-GRADE PEDIATRIC GLIOMAS

机译:THER-04。嗅鞘细胞将其自然路线从鼻腔转移到中枢神经系统然后将治疗性转基因药物转移至小儿神经胶质瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The olfactory ensheathing cells (OECs) are a unique glial cell type playing a role in promoting the axonal growth of neuronal receptors from the nasal mucosa towards the olfactory bulb during physiological turnover. OECs have the ability to migrate from the peripheral nervous system to the central nervous system, which is critical for the development of the olfactory system. Owing to their ability to guide axonal outgrowth, interact with astrocytes, and their immuno-modulatory and phagocytic properties, OECs showed promising results in regenerative medicine, including spinal cord injury and amyotrophic lateral sclerosis in the clinic, but were never studied in the context of cancer. Here, we evaluated for the first time OEC potential for pediatric gliblastoma gene therapy. We extracted/cultured OECs from mice olfactory bulb and established their phenotype by immunofluorescence microscopy. We first confirmed OEC tropism to intracranial glioblastoma, both at the primary tumor and the infiltrating single stem-like cells and showed that two cytokines, TNFα and IL-6, are responsible for this tropism. We chose the intranasal delivery since this route will bypass the blood-brain barrier, limit systemic side effects, and is the natural migration path of OECs to CNS. We then evaluated the potential of OEC as a delivery vehicle for pediatric glioma gene therapy by genetically engineering these cells to express cytosine deaminase (CD) under the control of CMV promoter. Mice bearing intracranial glioblastoma tumors injected intranasally with OEC-CD and treated with 5-FC showed slower tumor growth and increase in survival compared to controls. Our findings show for the first time OECs tropism to pediatric glioma tumors and their potential for brain cancer gene therapy using intranasal delivery. OECs have the advantage over other typical stem cells in that they can be easily obtained from olfactory bulb, allowing autologous transplantation and overcoming ethical issues.
机译:嗅鞘细胞(OEC)是一种独特的神经胶质细胞类型,在生理更新过程中,在促进神经元受体从鼻黏膜向嗅球的轴突生长中起作用。 OEC具有从周围神经系统迁移到中枢神经系统的能力,这对于嗅觉系统的发育至关重要。由于OEC具有指导轴突生长,与星形胶质细胞相互作用以及其免疫调节和吞噬特性的能力,因此它们在再生医学中显示出令人鼓舞的结果,包括临床上的脊髓损伤和肌萎缩性侧索硬化症,但从未在此方面进行过研究。癌症。在这里,我们首次评估了小儿胶质母细胞瘤基因治疗的OEC潜力。我们从小鼠嗅球中提取/培养了OEC,并通过免疫荧光显微镜确定了它们的表型。我们首先在原发性肿瘤和浸润的单个干样细胞中证实了OEC向颅内胶质母细胞瘤的向性,并表明两种细胞因子TNFα和IL-6负责这种向向性。我们选择鼻内给药,因为该途径将绕过血脑屏障,限制全身性副作用,并且是OEC向CNS的自然迁移途径。然后,我们通过基因工程改造这些细胞以在CMV启动子的控制下表达胞嘧啶脱氨酶(CD),评估了OEC作为儿童神经胶质瘤基因治疗的载体的潜力。与对照组相比,经鼻腔内注射OEC-CD并经5-FC治疗的颅内成胶质细胞瘤小鼠表现出较慢的肿瘤生长和存活率的提高。我们的研究结果首次显示了OECs对小儿神经胶质瘤肿瘤的嗜性及其使用鼻内给药进行脑癌基因治疗的潜力。 OEC与其他典型干细胞相比具有优势,因为它们可以轻松地从嗅球中获得,从而允许自体移植并克服了道德问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号